Interleukin-2 trials for Lung cancer

All Interleukin-2 trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Interleukin-2 for Lung cancer

• Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
  NCT07192900 · Phase: Phase 1 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location
• TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
  NCT06538012 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 90 Years · Sex: All (male and female) · 1 location
• TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
  NCT06532799 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 90 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Interleukin-2 for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.